title: Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.
authors.forename: Kah-Lok
authors.initials: KL
authors.lastname: Chan
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.
authors.forename: Piers
authors.initials: P
authors.lastname: Blombery
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.
authors.forename: Kate
authors.initials: K
authors.lastname: Jones
authors.affiliation: Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Victoria, Australia.
authors.forename: Stephen
authors.initials: S
authors.lastname: Lade
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.
authors.forename: Dennis
authors.initials: D
authors.lastname: Carney
authors.affiliation: Department of Haematology, Frankston Hospital, Victoria, Australia.
authors.forename: Huy
authors.initials: H
authors.lastname: Tran
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.|The University of Melbourne, Victoria, Australia.
authors.forename: John F
authors.initials: JF
authors.lastname: Seymour
authors.affiliation: Department of Haematology, Peter MacCallum Cancer Centre, Victoria, Australia.|The University of Melbourne, Victoria, Australia.
authors.forename: Constantine S
authors.initials: CS
authors.lastname: Tam
mesh_terms: D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D016403:Lymphoma, Large B-Cell, Diffuse; D010950:Plasma Cells
keywords: B-cell receptor signalling inhibitors; Chronic lymphocytic leukaemia; ibrutinib; plasmablastic lymphoma; richter transformation